Paracrine
CA - San DiegoBiotechnology
Focus: Paracrine is a San Diego-based regenerative cell therapy biotech focused on gene therapy and cell therapy modalities. The company is advancing autologous adipose-derived regenerative cells (ADRCs) and exosome-based therapeutics for unmet needs in dermatology and metabolic disease.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Paracrine
AI assessmentNot HiringNo open roles listed right now. Follow Paracrine to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Exosome ointment
PsoriasisClinical Trials (1)
NCT05523011Safety and Tolerability Study of MSC Exosome Ointment
Phase 1Help build intelligence for Paracrine
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.